Prospective, observational study of antiplatelet and coagulation biomarkers as predictors of thromboembolic events after implantation of ventricular assist devices
- 1 February 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Clinical Practice Cardiovascular Medicine
- Vol. 6 (2), 147-157
- https://doi.org/10.1038/ncpcardio1441
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Cerebrovascular accidents in patients with a ventricular assist deviceThe Journal of Thoracic and Cardiovascular Surgery, 2007
- Determination of Aspirin Responsiveness by Use of Whole Blood Platelet AggregometryClinical Chemistry, 2007
- Aprotinin Shows Both Hemostatic and Antithrombotic Effects During Off-Pump Coronary Artery Bypass GraftingThe Annals of Thoracic Surgery, 2006
- Platelet Function Testing in Cardiovascular DiseasesCirculation, 2004
- Lack of aspirin effect: aspirin resistance or resistance to taking aspirin?American Heart Journal, 2004
- Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart FailureNew England Journal of Medicine, 2001
- Tissue Plasminogen Activator, Plasminogen Activator Inhibitor-1, and Tissue Plasminogen Activator/Plasminogen Activator Inhibitor-1 Complex as Risk Factors for the Development of a First StrokeStroke, 2000
- Markers of Thrombin and Platelet Activity in Patients With Atrial FibrillationStroke, 1999
- A comparison of the effects of aspirin on bleeding time measured using the Simplate™ method and closure time measured using the PFA‐100™, in healthy volunteersBritish Journal of Clinical Pharmacology, 1997
- Guidance of anticoagulation after intracoronary implantation of palmaz-schatz stents by monitoring prothrombin and prothrombin fragment 1 + 2American Heart Journal, 1995